Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring
The 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery.
Projectdetails
Introduction
Cardiovascular diseases are the leading cause of death globally. Monitoring heart functions and ischemia is critical for survival after cardiac surgery. Standard monitoring methods such as echocardiogram and ELISA blood tests provide single-time measurements.
Limitations of Current Methods
These methods are available only in hospitals, and there is no continuous monitoring method after patients are discharged. This leads to a high rate of recurrent heart failures and rehospitalization.
Challenges with Implantable Devices
Implantable medical devices are used for the treatment of various disorders. However, their non-resorbable nature necessitates an implant removal surgery that puts additional risk of infection and stress on patients. This limitation restricts their use in postoperative monitoring.
The Promise of Bioresorbable Implants
Bioresorbable implants may soon revolutionize postoperative monitoring methods. The surgeon will implant a small patch onto the heart during surgery, enabling continuous cardiac monitoring and early alerts for heart failure.
Benefits of Bioresorbable Implants
This approach will:
- Reduce sudden attacks
- Decrease rehospitalizations
- Lower the financial burden of healthcare
Once the monitoring period ends, triggering with a light source will dissolve the implant, providing a significant second chance for survivors of cardiac failure without the burden of secondary surgery.
Current Technological Limitations
The technological advancements to bring this vision to the clinic are not available yet.
Project Overview: 2ND-CHANCE
2ND-CHANCE will facilitate this vision by building components of next-generation wireless implants with triggered bioresorption for cardiac surgery through ground-breaking approaches.
Project Goals
This interdisciplinary project aims to develop:
- Bioresorbable sensors compatible with the in-body environment
- Battery-free ultrasonic communication
- Encapsulation layer with triggered bioresorption
- Integration and animal tests
Broader Implications
The versatility of the 2ND-CHANCE project will also yield potential breakthroughs in fields where monitoring of tissues and biomarkers is crucial, such as neurology and ophthalmology, and will open new research perspectives.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-6-2022 |
Einddatum | 31-5-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- KOC UNIVERSITYpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Deep-Body Wireless Bioelectronics Enabled by Physics-Based Bioadaptive Wave ControlThe project aims to develop bio-adaptive wave control technologies for efficient powering and precise control of wireless bioelectronic implants in the body, enhancing medical monitoring and therapy delivery. | ERC Starting... | € 1.499.973 | 2025 | Details |
Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare. | ERC Starting... | € 1.500.000 | 2025 | Details |
Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden deathDevelop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease. | ERC Advanced... | € 2.488.400 | 2022 | Details |
Biodegradable MEMS implants for nerve repairDevelop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury. | ERC Starting... | € 1.672.968 | 2023 | Details |
Multianalyte Continuum Nanopores SensingMC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment. | ERC Proof of... | € 150.000 | 2024 | Details |
Deep-Body Wireless Bioelectronics Enabled by Physics-Based Bioadaptive Wave Control
The project aims to develop bio-adaptive wave control technologies for efficient powering and precise control of wireless bioelectronic implants in the body, enhancing medical monitoring and therapy delivery.
Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.
Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare.
Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death
Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.
Biodegradable MEMS implants for nerve repair
Develop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury.
Multianalyte Continuum Nanopores Sensing
MC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
Draadloze pacemaker en slimme monitoringDit project ontwikkelt een draadloze pacemaker met slimme monitoring om patiënten beter te behandelen en zorgkosten te verlagen. | Mkb-innovati... | € 20.000 | 2023 | Details |
In-vessel implantable smart sensing device for personalised medicineThe IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations. | EIC Pathfinder | € 4.158.610 | 2023 | Details |
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosisVesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs. | EIC Accelerator | € 2.500.000 | 2022 | Details |
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic DrugsDevelop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery. | EIC Pathfinder | € 2.606.250 | 2022 | Details |
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.
Draadloze pacemaker en slimme monitoring
Dit project ontwikkelt een draadloze pacemaker met slimme monitoring om patiënten beter te behandelen en zorgkosten te verlagen.
In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis
VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs
Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.